HJHarmony Johnson

Harmony Johnson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Harmony Johnson has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Descriptive Analysis of British Columbia’s Decriminalization Policy and its Impact on Access to Substances and Patterns of Use: Insights from the Road to Recovery Study

    by Elizabeth Carr, Rhea Beauchesne, Brittany Dennis, Travis De Wolfe, Harmony Johnson, Cheyenne Johnson, Seonaid Nolan

    Objectives: In January 2023, British Columbia (BC) received an exemption from federal legislation removing criminal penalties for possession of ≤ 2.5 g of unregulated drugs for personal use. This study aimed to identify perceived impacts of BC’s decriminalization policy on access to substances and patterns of use among patients accessing withdrawal management services. Methods: Data were collected through a cross-sectional survey of individuals enrolled in the Road to Recovery study [NCT06639373]. Participants who reported unregulated substance use (In this document, the term “unregulated substances” is used interchangeably with “previously designated criminalized substances,” which are defined as nonprescribed opioids, crack and/or powder cocaine, methamphetamines, and/or MDMA.) in the preceding 30 days were asked whether implementation of BC’s decriminalization policy impacted: (a) access to substances and/or (b) patterns of substance use. Results were summarized using descriptive statistics. Results: Among 91 eligible study participants, 50% identified as men, median age was 36 years (IQR: 18–73), 60% were white, and 88% had a lifetime history of unstable housing. Diagnosed substance use disorders included: 74% tobacco, 74% opioid, 57% stimulant, and 30% alcohol. Over half of participants (51%) felt implementation of BC’s decriminalization policy did not make it easier to access substances, compared with one-third (36%) who thought it did. Almost three-quarters (72%) believed the policy had no impact on their substance use patterns. Among 16% of participants who reported a change, 11% reported an increase, and 5% reported a decrease in substance use, respectively. Conclusions: Implementation of BC’s decriminalization policy had no perceived impact on patterns of substance use nor improved access to substances among the majority of study participants. Future research should examine association of the policy with health and social outcomes. Objectifs: En janvier 2023, la Colombie-Britannique (C.-B.) a obtenu une dérogation à la législation fédérale, supprimant ainsi les sanctions pénales pour la possession de moins de 2,5 grammes de drogues non réglementées à usage personnel. Cette étude visait à identifier les impacts perçus de la politique de décriminalisation de la C.-B. sur l’accès aux substances et les habitudes de consommation chez les patients bénéficiant de services de prise en charge du sevrage. Méthodes: Les données ont été recueillies au moyen d’une enquête transversale menée auprès de personnes participant à l’étude « Road to Recovery » [NCT06639373]. Les participants ayant déclaré avoir consommé des substances non réglementées au cours des 30 jours précédents ont été interrogés sur l’impact de la mise en œuvre de la politique de décriminalisation de la C.-B. sur : (a) l’accès aux substances ; et/ou (b) les habitudes de consommation. Les résultats ont été synthétisés à l’aide de statistiques descriptives. Résultats: Parmi les 91 participants éligibles à l’étude, 50% s’identifiaient comme des hommes, l’âge médian était de 36 ans (IQR : 18-73), 60% étaient de race blanche et 88% avaient des antécédents de situation de logement instable au cours de leur vie. Les troubles liés à la consommation de substances dont le diagnostic a été posé comprenaient : 74% pour le tabac, 74% pour les opiacés, 57% pour les stimulants et 30% pour l’alcool. Plus de la moitié des participants (51%) estimaient que la mise en œuvre de la politique de décriminalisation de la C.-B. n’avait pas facilité l’accès aux substances, contre un tiers (36%) qui pensaient le contraire. Près des trois quarts (72%) estimaient que cette politique n’avait eu aucun impact sur leurs habitudes de consommation. Parmi les 16% de participants ayant signalé un changement, 11% ont fait état d’une augmentation et 5% d’une diminution de leur consommation de substances, respectivement. Conclusions: La mise en œuvre de la politique de décriminalisation de la C.-B. n’a eu, selon la majorité des participants à l’étude, aucun impact perçu sur leurs habitudes de consommation de substances ni n’a amélioré l’accès à ces substances. De futures recherches devraient examiner le lien entre cette politique et les résultats en matière de santé et dans le domaine social.

  • Open Access

    Patient experiences and perceived efficacy of a newly implemented hospital-based withdrawal management unit in Vancouver, Canada: findings from the Road to Recovery evaluation

    by Sidney Roberge, Seonaid Nolan, Cheyenne Johnson, Piper Dickhout, Ava Abramowich, Travis De Wolfe, Renee Janssen, Erika Mundel, Andrea Ryan, Ian Haynes, et al.

    Background: The Road to Recovery (R2R) initiative represents an innovative approach to substance use care in British Columbia, Canada, that is designed to provide timely, comprehensive, and culturally safe services for individuals with a substance use disorder (SUD). This survey sought to understand patient experiences with this new care model. Methods: Adults (≥ 18 years) with a SUD who accessed R2R’s new hospital-based withdrawal management unit in Vancouver, Canada between May 2024 and April 2025 were invited to participate in a cross-sectional survey that captured their individual experiences. Descriptive statistics were used to summarize responses. Results: 87 participants completed the survey. The mean age was 41 years (Standard Deviation [SD] = 15); 57% ( n = 50) identified as male, and 49% ( n = 43) as Indigenous. The majority ( n = 58, 67%) of respondents reported access to withdrawal management services in ≤ 48 h. A total of 91% ( n = 79) of participants felt the quality of care was ‘good’ or ‘excellent’, 90% ( n = 78) reported positive interactions with staff, 88% ( n = 68) of respondents felt their withdrawal symptoms were adequately managed, 91% ( n = 71) believed the program helped them achieve their treatment goals. Among participants visited by Indigenous Wellness Liaisons (IWLs) (n = 56), 77% ( n = 43) completely trusted IWLs, and 52% ( n = 17) reported that their cultural and spiritual needs were completely met by IWLs. Peer support was valued by 85% of respondents for providing empathy and motivation. One-third ( n = 29, 33%) of participants contemplated leaving during their admission, most commonly because of the absence of engaging activities ( n = 12, 41%,). Overall, 95% said they would recommend the program to others. Conclusions: Findings highlight that the R2R model delivers timely, high-quality, and culturally safe withdrawal management care. Patients emphasized the value of respectful staff, effective medical management, and integration of Indigenous and peer supports. Enhancing structured programming and expanding access to psychosocial and cultural services may further improve engagement and reduce early discharge. Embedding trauma-informed, interdisciplinary, and culturally grounded approaches within hospital-based withdrawal management may improve patient experience and retention, informing future models of addiction care in Canada.